New Manhattanville campus + CTV license news
View this email in your browser
Dear colleagues,

Just last month, I had the opportunity to be a part of a historic development – the official ribbon cutting for Columbia University’s new Manhattanville campus, which stretches from 125th to 132nd streets, and runs from Broadway all the way to the Hudson River.  Scientists from Columbia's Mortimer B. Zuckerman Mind Brain Behavior Institute will reside in the Jerome L. Greene Science Center, the first building to open on the new Manhattanville Campus. 

The Zuckerman Institute, led by Eric Kandel, Richard Axel, and Thomas Jessell will bring together over 1000 Columbia researchers to “close the gap between our genetic and molecular understanding of the brain and what the social sciences, humanities, and professional disciplines tell us about behavior,” as President Bollinger said.  From neurological diseases to the complexity of human behavior, the scientific innovations that will emerge from the Zuckerman Institute will no doubt have a profound impact on society.  

Columbia Technology Ventures is proud to be an enthusiastic collaborator in this new endeavor. Our Senior Licensing Officer Ron Katz will serve as the Associate Director of Licensing for Manhattanville, and will lead CTV’s efforts at the new campus.

Best wishes,

Orin Herskowitz
Executive Director, CTV
Senior VP for Intellectual Property & Technology Transfer
Columbia University recently announced an exclusive licensing deal with Leica Microsystems to commercialize Prof. Elizabeth Hillman's SCAPE microscopy for life science applications. Prof. Hillman is an Associate Professor of Biomedical Engineering and a member of the Zuckerman Institute. SCAPE (swept confocally aligned planar excitation) microscopy forms 3D images of living samples by scanning them with a sheet of laser light. SCAPE’s unique capabilities allow scientists to perform fundamentally new kinds of experiments, from imaging individual neurons firing throughout the brain of adult fruit flies, to tracking calcium waves through cells in the beating heart of a zebrafish. SCAPE also stands to create new inroads for understanding diseases such as cancer, and for the development of new drugs and therapies. Learn more here.
Friday, 12/9, 1pm - Advanced Tactics Design Workshop: Facilitating Creative Teams - This is an advanced tactic workshop demonstrating how to lead a team through a design process, with focus on developing environments that encourage creative behaviors leading to novel ideas.

Friday, 12/9, 6pm - Fireside Chat and Reception with Stephen Gorevan of Honey Bee - Join us in welcoming the founder of New York's robotic scene Stephen Gorevan of Honey Bee Robotics, who has built some of the most ground breaking mechatronic innovations on Earth and Mars, as well as CTV's Satish Rao, Associate Director of Physical Sciences Licensing.
Deadline Thursday, 12/1 - Call for Pre-Proposals: Columbia-Coulter Biomedical Accelerator - The Columbia-Coulter Translational Research Partnership is accepting pre-proposals for biomedical technologies based on Columbia intellectual property with the potential to directly impact human health. Most relevant are technologies in which the time to market can be achieved in 7 to 10 years.

Call for Proposals: Allied-Bristol Life Sciences - Apply for the CATALYST program, which aims to identify and develop commercially-promising biopharmaceutical innovations from leading universities and research institutions.
Wearable device for continuous blood glucose monitoring | Learn more

Injectable microtissues for vascular tissue regeneration | Learn more

Single-photon avalanche diodes (SPADs) for high-speed fluorescence imaging | Learn more

Rapid interferer detector for next-generation wireless networks | Learn more

Noise-cancelling wideband receiver for software-defined radio | Learn more

Columbia University has over 1200 active patent assets available for licensing. Click here to discover more
Have something you'd like to see included? Email
Copyright © 2016 Columbia Technology Ventures, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list